The Gold Cone X-Flo Filter Cartridge from Camfil APC stays cleaner and lasts longer than conventional pleated filters.
Image courtesy of Camfil APC.
The Gold Cone X-Flo (GCX) Filter Cartridge from Camfil Air Pollution Control (APC) is designed for high-efficiency industrial dust collection. Building on the company’s HemiPleat Gold Cone technology, GCX filters stay cleaner and last longer than conventional pleated filters.
The filter cartridges use a proprietary inner pleat pack with an open-bottomed, inner-cone of media that greatly expands the usable surface area of the cartridge. Because the HemiPleat design exposes more media to the airstream, more dust is loaded on the filter and released during pulse cleaning. These filters are available in a selection of regular or nano-fiber media to meet particle emission requirements.
GCX filters were designed specifically for Camfil APC's new Gold Series X-Flo (GSX) dust collector. The unique location of the filter in the collector enables more downward-facing media than standard, competitive systems. The cone is configured so that pulsed air is evenly distributed top to bottom along the outer pack of the filter and down through the inner cone pack. That means with each pulse, the cone cartridge ejects more dust out of the collector, straight down to the hopper. This design offers an advantage over horizontal-style filters that pulse most of the dust back onto adjacent filters. Used together, the GSX collector and GCX filter system maximizes airflow while minimizing filter change-outs, compressed air usage, and energy costs.
Source: Camfil APC
FDA Approves First Treatment for Rare Lipid Storage Disease Cerebrotendinous Xanthomatosis
February 24th 2025Cerebrotendinous xanthomatosis, or CTX, is a metabolic disorder caused by a gene mutation that results in a deficiency of an important enzyme in the ability of the human body to break down fats.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.